NYPOZI

Formula & Concentration

NYPOZI – filgrastim-txid 300 mcg/0.5 mL injection syringe

Manufacturer

Cipla USA Inc.

Indications

Severe chronic neutropenia; cyclic neutropenia; peripheral mobilization of hematopoietic stem cells; drug-induced neutropenia; prevention of neutropenia from cancer chemotherapy; chemotherapy-induced neutropenia; AIDS-associated neutropenia; myeloid engraftment enhancement; hematopoietic syndrome of acute radiation syndrome; neutropenia secondary to AML treatment; myelodysplastic syndrome; congenital neutropenia; idiopathic neutropenia

Product Options

Package Size

NDC #

Presentation

300 mcg/0.5

72374-0101-01

Syringe

300 mcg/0.5

72374-0101-10

Syringe

480 mcg/0.8

72374-0102-01

Syringe

480 mcg/0.8

72374-0102-10

Syringe

Shelf Life and Storage

Fridge (2-8°C)